Application and risk assessment of intraoperative cell salvage in patient with malignancy
10.13303/j.cjbt.issn.1004-549x.2022.03.030
- VernacularTitle:回收式自体输血在恶性肿瘤患者手术中的应用及风险评估
- Author:
Zhenzhou LI
1
;
Yaru CHEN
2
;
Jianrong GUO
3
Author Information
1. Department of Anesthesiology & Perioperative Medicine, Shanghai Pudong Gongli Hospital, Naval Military Medical University, Shanghai 200135, China; General Hospital of Ningxia Medical University
2. General Hospital of Ningxia Medical University
3. Department of Anesthesiology & Perioperative Medicine, Shanghai Pudong Gongli Hospital, Naval Military Medical University, Shanghai 200135, China
- Publication Type:Journal Article
- Keywords:
intraoperative cell salvage;
malignancy;
surgery;
risk
- From:
Chinese Journal of Blood Transfusion
2022;35(3):345-348
- CountryChina
- Language:Chinese
-
Abstract:
Patients with malignant tumour often require massive transfusion. Intraoperative cell salvage(IOCS) was initially limited in cancer surgery by concerns about the possibility of dissemination of tumor cells into circulation. However, as supportive literature concerning IOCS research and application in cancer surgery are increasing, it is necessary to reassess the perioperative application of IOCS in patients with malignancy. This review summarizes the application, risks and value of IOCS during cancer operations.
